Cholesterol biosynthesis from lanosterol: Development of a novel assay method, characterization, and solubilization of rat hepatic microsomal sterol Δ7-reductase

Joon No Lee, Young Ki Paik

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A novel assay method is described for rapid quantitation of reaction rate of sterol Δ7-reductase (Δ 7-SR) which catalyzes reduction of the Δ7-double bond of sterols. Of six different organ tissues-liver, small intestine, brain, lung, kidney, and testis-, Δ7-SR activity was detected only in liver (2.30 nmol/min/mg protein) and testis (0.11 nmol/min/mg protein). Using a newly developed method which employs diet-induced enzyme proteins and ergosterol as substrate, we assessed both kinetics (Km=210 μM, Vmax=1.93 nmol/min/mg) and inhibition of the rat hepatic Δ7-SR against well-studied cholesterol lowering agents such as triparanol (IC50=16 μM). 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A) (IC50=5.2 μM), and trans-1,4-bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride (AY-9944) (IC50=0.25 μM). Of the three well-known AY-9944-sensitive cholesterogenic enzymes (i.e., Δ7-SR, sterol Δ8-isomerase, and sterol Δ14-reductase), Δ7-SR was found to be the most sensitive enzyme with a noncompetitive inhibition of this compound (Ki=0.109 μM). Substrate specificity studies of the microsomal Δ7-SR indicate that the relative reaction rate for 7-dehydrocholesterol and ergosterol are 5.6-fold and 1.6-fold higher than that for lathosterol. Δ7-SR activity was also modulated by feeding rats a diet supplemented with 0.5% ergosterol (>2.6-fold) in addition to 5.0% cholestyramine plus 0.1% lovastatin (≃5.0-fold). Finally, microsomal Δ7-SR was solubilized by 1.5% 3-[3-(cholamidopropyl)-dimethylammoniol-1-propanesulfonate (CHAPS) and enriched on PEG (0∼10%) precipitation, which should be suitable for further purification of the enzyme.

Original languageEnglish
Pages (from-to)370-377
Number of pages8
JournalJournal of Biochemistry and Molecular Biology
Volume30
Issue number5
Publication statusPublished - 1997 Sep 30

Fingerprint

Lanosterol
Biosynthesis
Sterols
Ergosterol
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride
Rats
Assays
Oxidoreductases
Cholesterol
Inhibitory Concentration 50
Liver
Enzymes
Nutrition
Reaction rates
Testis
Triparanol
Diet
Cholestyramine Resin
Lovastatin
Proteins

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology

Cite this

@article{c5ae45d792024349997dcce4ccee9507,
title = "Cholesterol biosynthesis from lanosterol: Development of a novel assay method, characterization, and solubilization of rat hepatic microsomal sterol Δ7-reductase",
abstract = "A novel assay method is described for rapid quantitation of reaction rate of sterol Δ7-reductase (Δ 7-SR) which catalyzes reduction of the Δ7-double bond of sterols. Of six different organ tissues-liver, small intestine, brain, lung, kidney, and testis-, Δ7-SR activity was detected only in liver (2.30 nmol/min/mg protein) and testis (0.11 nmol/min/mg protein). Using a newly developed method which employs diet-induced enzyme proteins and ergosterol as substrate, we assessed both kinetics (Km=210 μM, Vmax=1.93 nmol/min/mg) and inhibition of the rat hepatic Δ7-SR against well-studied cholesterol lowering agents such as triparanol (IC50=16 μM). 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A) (IC50=5.2 μM), and trans-1,4-bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride (AY-9944) (IC50=0.25 μM). Of the three well-known AY-9944-sensitive cholesterogenic enzymes (i.e., Δ7-SR, sterol Δ8-isomerase, and sterol Δ14-reductase), Δ7-SR was found to be the most sensitive enzyme with a noncompetitive inhibition of this compound (Ki=0.109 μM). Substrate specificity studies of the microsomal Δ7-SR indicate that the relative reaction rate for 7-dehydrocholesterol and ergosterol are 5.6-fold and 1.6-fold higher than that for lathosterol. Δ7-SR activity was also modulated by feeding rats a diet supplemented with 0.5{\%} ergosterol (>2.6-fold) in addition to 5.0{\%} cholestyramine plus 0.1{\%} lovastatin (≃5.0-fold). Finally, microsomal Δ7-SR was solubilized by 1.5{\%} 3-[3-(cholamidopropyl)-dimethylammoniol-1-propanesulfonate (CHAPS) and enriched on PEG (0∼10{\%}) precipitation, which should be suitable for further purification of the enzyme.",
author = "Lee, {Joon No} and Paik, {Young Ki}",
year = "1997",
month = "9",
day = "30",
language = "English",
volume = "30",
pages = "370--377",
journal = "BMB Reports",
issn = "1976-6696",
publisher = "The Biochemical Society of the Republic of Korea",
number = "5",

}

TY - JOUR

T1 - Cholesterol biosynthesis from lanosterol

T2 - Development of a novel assay method, characterization, and solubilization of rat hepatic microsomal sterol Δ7-reductase

AU - Lee, Joon No

AU - Paik, Young Ki

PY - 1997/9/30

Y1 - 1997/9/30

N2 - A novel assay method is described for rapid quantitation of reaction rate of sterol Δ7-reductase (Δ 7-SR) which catalyzes reduction of the Δ7-double bond of sterols. Of six different organ tissues-liver, small intestine, brain, lung, kidney, and testis-, Δ7-SR activity was detected only in liver (2.30 nmol/min/mg protein) and testis (0.11 nmol/min/mg protein). Using a newly developed method which employs diet-induced enzyme proteins and ergosterol as substrate, we assessed both kinetics (Km=210 μM, Vmax=1.93 nmol/min/mg) and inhibition of the rat hepatic Δ7-SR against well-studied cholesterol lowering agents such as triparanol (IC50=16 μM). 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A) (IC50=5.2 μM), and trans-1,4-bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride (AY-9944) (IC50=0.25 μM). Of the three well-known AY-9944-sensitive cholesterogenic enzymes (i.e., Δ7-SR, sterol Δ8-isomerase, and sterol Δ14-reductase), Δ7-SR was found to be the most sensitive enzyme with a noncompetitive inhibition of this compound (Ki=0.109 μM). Substrate specificity studies of the microsomal Δ7-SR indicate that the relative reaction rate for 7-dehydrocholesterol and ergosterol are 5.6-fold and 1.6-fold higher than that for lathosterol. Δ7-SR activity was also modulated by feeding rats a diet supplemented with 0.5% ergosterol (>2.6-fold) in addition to 5.0% cholestyramine plus 0.1% lovastatin (≃5.0-fold). Finally, microsomal Δ7-SR was solubilized by 1.5% 3-[3-(cholamidopropyl)-dimethylammoniol-1-propanesulfonate (CHAPS) and enriched on PEG (0∼10%) precipitation, which should be suitable for further purification of the enzyme.

AB - A novel assay method is described for rapid quantitation of reaction rate of sterol Δ7-reductase (Δ 7-SR) which catalyzes reduction of the Δ7-double bond of sterols. Of six different organ tissues-liver, small intestine, brain, lung, kidney, and testis-, Δ7-SR activity was detected only in liver (2.30 nmol/min/mg protein) and testis (0.11 nmol/min/mg protein). Using a newly developed method which employs diet-induced enzyme proteins and ergosterol as substrate, we assessed both kinetics (Km=210 μM, Vmax=1.93 nmol/min/mg) and inhibition of the rat hepatic Δ7-SR against well-studied cholesterol lowering agents such as triparanol (IC50=16 μM). 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A) (IC50=5.2 μM), and trans-1,4-bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride (AY-9944) (IC50=0.25 μM). Of the three well-known AY-9944-sensitive cholesterogenic enzymes (i.e., Δ7-SR, sterol Δ8-isomerase, and sterol Δ14-reductase), Δ7-SR was found to be the most sensitive enzyme with a noncompetitive inhibition of this compound (Ki=0.109 μM). Substrate specificity studies of the microsomal Δ7-SR indicate that the relative reaction rate for 7-dehydrocholesterol and ergosterol are 5.6-fold and 1.6-fold higher than that for lathosterol. Δ7-SR activity was also modulated by feeding rats a diet supplemented with 0.5% ergosterol (>2.6-fold) in addition to 5.0% cholestyramine plus 0.1% lovastatin (≃5.0-fold). Finally, microsomal Δ7-SR was solubilized by 1.5% 3-[3-(cholamidopropyl)-dimethylammoniol-1-propanesulfonate (CHAPS) and enriched on PEG (0∼10%) precipitation, which should be suitable for further purification of the enzyme.

UR - http://www.scopus.com/inward/record.url?scp=0031510229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031510229&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031510229

VL - 30

SP - 370

EP - 377

JO - BMB Reports

JF - BMB Reports

SN - 1976-6696

IS - 5

ER -